Roeland Huijgen

2.2k citations

44 papers · 1.5k indexed · h-index 23

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
Surgery top 2%
- Lipoproteins and Cardiovascular Health 33
Cancer Research top 5%
- Cancer, Lipids, and Metabolism 10
Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 4
Cardiology and Cardiovascular Medicine top 5%
- Lipid metabolism and disorders 6
Economics and Econometrics
- Pharmaceutical Economics and Policy 5
- Health Systems, Economic Evaluations, Quality of Life 4
Hematology
- Blood Coagulation and Thrombosis Mechanisms 3

Co-authors: John J.P. Kastelein Barbara A. Hutten Maud N. Vissers Iris Kindt Joep C. Defesche G. Kees Hovingh Frank L.J. Visseren Ben P.M. Imholz
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Circulation (1 paper)Blood (2 papers)Journal of the American College of Cardiology (2 papers)
Partner nations: Netherlands United States South Africa

In The Last Decade

Roeland Huijgen

44 papers receiving 1.5k citations

Peers

Countries citing papers authored by Roeland Huijgen

Since Specialization

Citations

This map shows the geographic impact of Roeland Huijgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roeland Huijgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roeland Huijgen more than expected).

Fields of papers citing papers by Roeland Huijgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roeland Huijgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roeland Huijgen. The network helps show where Roeland Huijgen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roeland Huijgen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roeland Huijgen Line = papers co-authored together Roeland Huijgen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia Atherosclerosis ·Shirin Ibrahim,Merel L. Hartgers,Laurens F. Reeskamp,Linda Zuurbier,Joep C. Defesche,John J.P. Kastelein,Erik S.G. Stroes,G. Kees Hovingh,Roeland Huijgen	2024	2
2	Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model Journal of clinical lipidology ·Arjen J. Cupido,Michel H. Hof,Lotte M. de Boer,Roeland Huijgen,Erik S.G. Stroes,John J.P. Kastelein,G. Kees Hovingh,Barbara A. Hutten	2022	3
3	Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation Atherosclerosis ·Laurens F. Reeskamp,Tycho R. Tromp,Roeland Huijgen,Erik S.G. Stroes,G. Kees Hovingh,Aldo Grefhorst	2020	8
4	Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program Surgery for Obesity and Related Diseases ·Arnold van de Laar,Victor E. A. Gerdes,Roeland Huijgen,Yaïr I. Z. Acherman,Eelco W. Meesters,Max Nieuwdorp	2020	3
5	Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric Bypass Obesity Surgery ·Sylke Haal,Djoeke Rondagh,Barbara A. Hutten,Yaïr I. Z. Acherman,Arnold van de Laar,Roeland Huijgen,Victor E. A. Gerdes,Rogier P. Voermans	2019	18
6	LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C Atherosclerosis ·Xander M. van Delden,Roeland Huijgen,Karen Wolmarans,Brigitte C. Brice,Jennifer K. Barron,Dirk Blom,Adéle Marais	2018	10
7	Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy Journal of clinical lipidology ·Merel L. Hartgers,Joost Besseling,Erik S.G. Stroes,Janneke Wittekoek,Joost H.W. Rutten,Jacqueline de Graaf,Frank L.J. Visseren,Ben P.M. Imholz,Jeanine E. Roeters van Lennep,Roeland Huijgen,John J.P. Kastelein,G. Kees Hovingh	2018	17
8	Statins in Familial Hypercholesterolemia Journal of the American College of Cardiology ·Joost Besseling,G. Kees Hovingh,Roeland Huijgen,John J.P. Kastelein,Barbara A. Hutten	2016	129
9	Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia Atherosclerosis ·Joost Besseling,Roeland Huijgen,Seth S. Martin,Barbara A. Hutten,John J.P. Kastelein,G. Kees Hovingh	2015	5
10	PCSK9 inhibition: the way forward in the treatment of dyslipidemia BMC Medicine ·Robert M. Stoekenbroek,John J.P. Kastelein,Roeland Huijgen	2015	28
11	The impact of LDLR function on fibroblast growth factor 21 levels Atherosclerosis ·Joost Besseling,Kwok Leung Ong,Roeland Huijgen,Kerry‐Anne Rye,G. Kees Hovingh,Barbara A. Hutten,Gilles Lambert	2015	1
12	Increased carotid intima–media thickness predicts cardiovascular events in aortic coarctation International Journal of Cardiology ·Paul Luijendijk,Huangling Lu,Frederike B. Heynneman,Roeland Huijgen,Eric E. de Groot,Joris W.J. Vriend,Hubert W. Vliegen,Maarten Groenink,Berto J. Bouma,Barbara J.M. Mulder	2014	24
13	Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk Journal of Lipid Research ·D. Meeike Kusters,Hans J. Avis,Marjet J.A.M. Braamskamp,Roeland Huijgen,Frits A. Wijburg,John J.P. Kastelein,Albert Wiegman,Barbara A. Hutten	2013	18
14	Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia European Heart Journal ·Mohammad Mahdi Motazacker,James P. Pirruccello,Roeland Huijgen,Ron Do,Stacey Gabriel,Jorge Peter,Jan Albert Kuivenhoven,Joep C. Defesche,John J.P. Kastelein,G. Kees Hovingh,Noam Zelcer,Sekar Kathiresan,Sigrid W. Fouchier	2012	61
15	Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program The Journal of Pediatrics ·Hans J. Avis,D. Meeike Kusters,Maud N. Vissers,Roeland Huijgen,Thomas H. Janssen,Albert Wiegman,Iris Kindt,John J.P. Kastelein,Frits A. Wijburg,Barbara A. Hutten	2012	26
16	Factor VIII deficiency does not protect against atherosclerosis Journal of Thrombosis and Haemostasis ·Sara Biere‐Rafi,A. Tuinenburg,Bastiaan W. Haak,Matthew Peters,Roeland Huijgen,Eric de Groot,Peter Verhamme,Kathelijne Peerlinck,Frank L.J. Visseren,Marieke J.H.A. Kruip,Britta A. P. Laros‐van Gorkom,V.E.A. Gerdes,H R Büller,Roger E. G. Schutgens,Pieter W. Kamphuisen	2011	61
17	Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia Human Mutation ·Roeland Huijgen,Iris Kindt,Sigrid W. Fouchier,Joep C. Defesche,Barbara A. Hutten,John J.P. Kastelein,Maud N. Vissers	2010	33
18	Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal PLoS ONE ·Roeland Huijgen,Iris Kindt,Sjoerd B. J. Verhoeven,Eric J.G. Sijbrands,Maud N. Vissers,John J.P. Kastelein,Barbara A. Hutten	2010	96
19	Venous thrombosis is associated with hyperglycemia at diagnosis: a case–control study Journal of Thrombosis and Haemostasis ·Jeroen Hermanides,Danny M. Cohn,J. Hans DeVries,Pieter W. Kamphuisen,Roeland Huijgen,Joost C.M. Meijers,J. B. L. Hoekstra,Harry R. Büller	2009	35
20	Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands Atherosclerosis ·Annemarie H Pijlman,Roeland Huijgen,Sandra N. Verhagen,Ben P.M. Imholz,Anho Liem,John J.P. Kastelein,Evertine J. Abbink,Anton F. H. Stalenhoef,Frank L.J. Visseren	2009	220

About Roeland Huijgen

Roeland Huijgen is a scholar working on Internal Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Cancer, Lipids, and Metabolism (10 papers), Lipid metabolism and disorders (6 papers), Pharmaceutical Economics and Policy (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (470 citations), Surgery (1.2k citations) and Cancer Research (344 citations). Roeland Huijgen has collaborated with scholars based in Netherlands, United States and South Africa. Frequent co-authors include John J.P. Kastelein, Barbara A. Hutten, Maud N. Vissers, Iris Kindt, Joep C. Defesche, G. Kees Hovingh, Frank L.J. Visseren, Ben P.M. Imholz, Anton F. H. Stalenhoef and Evertine J. Abbink. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact